CoChat

Bone Lead Levels and Blood Pressure Endpoints: A Meta-Analysis

Navas-Acien, Ana, Schwartz, Brian S., Rothenberg, Stephen J., Hu, Howard, Silbergeld, Ellen K., Guallar, Eliseo · 2008 · Epidemiology
Cited by 95

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Previous reviews have shown increases in blood pressure and hypertension associated with increases in lead levels in blood. We performed a meta-analysis of the association of bone lead levels with systolic blood pressure, diastolic blood pressure, and hypertension using published data. METHODS: We searched Medline, Embase, and Toxline for epidemiologic studies on bone lead levels and blood pressure endpoints. We used inverse-variance weighted random-effects models to summarize the association of tibia or patella lead levels with blood pressure endpoints. RESULTS: We summarized data from 3 prospective studies and 5 cross-sectional studies. All studies measured lead levels in tibia bone and 3 studies measured lead levels in patella. For a 10 microg/g increase in tibia lead, the cross-sectional summary increases in blood pressure were 0.26 mm Hg for systolic (95% confidence interval = 0.02 to 0.50) and 0.02 mm Hg for diastolic (-0.15 to 0.19). The summary odds ratio for hypertension was 1.04 (1.01 to 1.07). For a 10 microg/g increase in patella lead, the summary odds ratio for hypertension was 1.04 (0.96 to 1.12). CONCLUSION: Systolic blood pressure and hypertension risk were associated with lead levels in tibia bone, but the magnitude of the summary estimates was small. These summary estimates, however, were based on published data and we could not evaluate nonlinear dose-response relationships, the relative contribution of bone and blood lead levels, or the influence of differences in study populations. A more detailed characterization of the association of bone lead levels and blood pressure endpoints would require a pooled analysis of individual participant data from existing studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/ede.0b013e31816a2400

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 30

  1. Navas-Acien, 2007, Lead exposure and cardiovascular disease—a systematic review., Environ Health Perspect, 115, 472, 10.1289/ehp.9785 · DOI · Paper page
  2. Sharp, 1987, Chronic low-level lead exposure. Its role in the pathogenesis of hypertension., Med Toxicol, 2, 210, 10.1007/BF03259865 · DOI
  3. Hertz-Picciotto, 1993, Review of the relation between blood lead and blood pressure., Epidemiol Rev, 15, 352, 10.1093/oxfordjournals.epirev.a036125 · doi:10.1093/oxfordjournals.epirev.a036125
  4. Staessen, 1995, Low-level lead exposure and blood pressure., J Hum Hypertens, 9, 303
  5. Nawrot, 2002, An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis., J Hum Hypertens, 16, 123, 10.1038/sj.jhh.1001300 · DOI · Paper page
  6. Schwartz, 1995, Lead, blood pressure, and cardiovascular disease in men., Arch Environ Health, 50, 31, 10.1080/00039896.1995.9955010 · DOI · Paper page
  7. Staessen, 1994, Hypertension caused by low-level lead exposure: myth or fact?, J Cardiovasc Risk, 1, 87, 10.1097/00043798-199406000-00014 · doi:10.1097/00043798-199406000-00014
  8. Hu, 1998, Bone lead as a new biologic marker of lead dose: recent findings and implications for public health., Environ Health Perspect, 106, 961, 10.1289/ehp.98106s4961 · doi:10.1289/ehp.98106s4961
  9. Barbosa, 2005, A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs., Environ Health Perspect, 113, 1669, 10.1289/ehp.7917 · DOI · Paper page
  10. Hu, 2007, The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues., Environ Health Perspect, 115, 455, 10.1289/ehp.9783 · DOI · Paper page
  11. Glenn, 2003, The longitudinal association of lead with blood pressure., Epidemiology, 14, 30, 10.1097/00001648-200301000-00011 · DOI
  12. Cheng, 2001, Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension: the Normative Aging Study., Am J Epidemiol, 153, 164, 10.1093/aje/153.2.164 · DOI · Paper page
  13. Gerr, 2002, Association between bone lead concentration and blood pressure among young adults., Am J Ind Med, 42, 98, 10.1002/ajim.10096 · doi:10.1002/ajim.10096
  14. Hu, 1996, The relationship of bone and blood lead to hypertension. The Normative Aging Study., JAMA, 275, 1171, 10.1001/jama.1996.03530390037031 · DOI · Paper page
  15. Korrick, 1999, Lead and hypertension in a sample of middle-aged women., Am J Public Health, 89, 330, 10.2105/AJPH.89.3.330 · DOI
  16. Lee, 2001, Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes., Environ Health Perspect, 109, 383
  17. Martin, 2006, Association of blood lead and tibia lead with blood pressure and hypertension in a community sample of older adults., Am J Epidemiol, 163, 467, 10.1093/aje/kwj060 · DOI
  18. Rothenberg, 2002, Increases in hypertension and blood pressure during pregnancy with increased bone lead levels., Am J Epidemiol, 156, 1079, 10.1093/aje/kwf163 · DOI
  19. Rothenberg, 2007, Re: “Increases in hypertension and blood pressure levels during pregnancy with increased bone lead levels.”, Am J Epidemiol, 166, 241, 10.1093/aje/kwm186 · doi:10.1093/aje/kwm186
  20. Schwartz, 2000, Different associations of blood lead, meso 2,3-dimercaptosuccinic acid (DMSA)-chelatable lead, and tibial lead levels with blood pressure in 543 former organolead manufacturing workers., Arch Environ Health, 55, 85, 10.1080/00039890009603392 · doi:10.1080/00039890009603392
  21. Longnecker, 1988, A meta-analysis of alcohol consumption in relation to risk of breast cancer., JAMA, 260, 652, 10.1001/jama.1988.03410050072032 · DOI · Paper page
  22. Higgins, 2002, Quantifying heterogeneity in a meta-analysis., Stat Med, 21, 1539, 10.1002/sim.1186 · DOI · Paper page
  23. Glenn, 2006, Changes in systolic blood pressure associated with lead in blood and bone., Epidemiology, 17, 538, 10.1097/01.ede.0000231284.19078.4b · doi:10.1097/01.ede.0000231284.19078.4b
  24. 2007, Increases in hypertension and blood pressure during pregnancy with increased bone lead levels [Erratum]., Am J Epidemiol, 166, 241, 10.1093/aje/kwm186 · doi:10.1093/aje/kwm186
  25. Blettner, 1999, Traditional reviews, meta-analyses and pooled analyses in epidemiology., Int J Epidemiol, 28, 1, 10.1093/ije/28.1.1 · DOI · Paper page
  26. Elmarsafawy, 2006, Dietary calcium as a potential modifier of the relationship of lead burden to blood pressure., Epidemiology, 17, 531, 10.1097/01.ede.0000231285.86968.2b · doi:10.1097/01.ede.0000231285.86968.2b
  27. Emberson, 2004, Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study., Eur J Cardiovasc Prev Rehabil, 11, 125, 10.1097/01.hjr.0000114967.39211.e5 · DOI · Paper page
  28. Pirkle, 1994, The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES)., JAMA, 272, 284, 10.1001/jama.1994.03520040046039 · DOI · Paper page
  29. Muntner, 2005, Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys., Arch Intern Med, 165, 2155, 10.1001/archinte.165.18.2155 · DOI · Paper page
  30. Whelton, 2002, Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program., JAMA, 288, 1882, 10.1001/jama.288.15.1882 · DOI · Paper page

Cited by

See all 95

Metadata

Authors
Navas-Acien, A., Schwartz, B. S., Rothenberg, S. J., Hu, H., Silbergeld, E. K., & Guallar, E.
Venue
Epidemiology
Published
2008-05
Volume
19
Issue
3
Pages
496-504
ISSN
1044-3983 (ISSN-L)
OpenAlex
W2087999767
Cited by
95
References
2
FWCI
3.89
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.